MoneyWorks4Me

Lupin informs about press release

28 Dec 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 28th December 2020 as regards the launch by the Company of Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the US FDA, titled ‘Lupin launches Meloxicam Capsules’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.40
Dr. Reddys Labs. 1316.00
Cipla 1358.70
Lupin 1954.35
Zydus Lifesciences 1167.65
View more..